Evidence map›Paper›PMID 18951849›Full record

ArticleClinical immunology (Orlando, Fla.)2009

A locus on chromosome 1 promotes susceptibility of experimental autoimmune myocarditis and lymphocyte cell death.

Davinna L Ligons, Mehmet L Guler, Haiyan S Li, Noel R Rose

Abstract read
In one paragraph

Article in Clinical immunology (Orlando, Fla.), 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.8field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 13 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Davinna L LigonsDepartment of Pathology, Johns Hopkins Medical Institutions, Baltimore, MD 21205, USA.
Mehmet L Guler
Haiyan S Li
Noel R Rose
Johns Hopkins University · US

Funding

Pathogenesis of Autoimmune MyocarditisR01HL067290 · NHLBI · JOHNS HOPKINS UNIVERSITY · PI ROSE, NOEL R. · 2002 to 2009
$3.0M
Genetic mechanisms of autoimmune myocarditisR01HL077611 · NHLBI · JOHNS HOPKINS UNIVERSITY · PI ROSE, NOEL R. · 2004 to 2007
$1.4M
Genetic mechanisms of autoimmune myocarditisR56HL077611 · NHLBI · JOHNS HOPKINS UNIVERSITY · PI ROSE, NOEL R. · 2009 to 2009
$369k
NHLBI NIH HHS HL067290NHLBI NIH HHS HL077611NHLBI NIH HHS R01 HL067290NHLBI NIH HHS R01 HL077611NHLBI NIH HHS R56 HL077611
6 · The paper itself

Abstract

We previously identified by linkage analysis a region on chromosome 1 (Eam1) that confers susceptibility to experimental autoimmune myocarditis (EAM). To evaluate the role of Eam1, we created a congenic mouse strain, carrying the susceptible Eam1 locus of A.SW on the resistant B10.S background (B10.A-Eam1 congenic) and analyzed three outcomes: 1) the incidence and severity of EAM, 2) the susceptibility of lymph node cells (LNCs) to Cy-enhanced cell death, and 3) susceptibility of lymphocytes to antigen-induced cell death. Incidence of myocarditis in B10.A-Eam1 congenic mice was comparable to A.SW mice, confirming that Eam1 plays an important role in disease development. Caspase 3, 8 and 9 activation in LNCs following Cy treatment and in CD4(+) T cells after immunization with myosin/CFA was significantly lower in A.SW than B10.S mice whereas B10.A-Eam1 congenic mice exhibited an intermediate phenotype. Our results show that Eam1 reduces lymphocyte apoptosis and increases susceptibility to EAM.

Indexed as

AnimalsAutoimmune DiseasesCaspasesCell DeathChromosomes, MammalianEnzyme ActivationGenetic Predisposition to DiseaseImmunizationLymphocyte ActivationLymphocytesMaleMiceMyocarditisMyosinsCaspasesMyosins

Identifiers

PMID18951849
PMCPMC2640841
OpenAlexW2071329325

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.